AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial.

@article{Delgado2016AbobotulinumtoxinAFE,
  title={AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial.},
  author={Mauricio R. Delgado and Ann Henderson Tilton and Barry S. Russman and Oscar Benavides and Marcin Bonikowski and Jorge Carranza and Edward Dabrowski and Nigar Dursun and Mark E. Gormley and Marek J{\'o}źwiak and Dennis J Matthews and Iwona Maciag-Tymecka and Ece Unlu and Emmanuel Pham and Anissa Tse and Philippe Picaut},
  journal={Pediatrics},
  year={2016},
  volume={137 2},
  pages={e20152830}
}
BACKGROUND Although botulinum toxin is a well-established treatment of focal spasticity in cerebral palsy, most trials have been small, and few have simultaneously assessed measures of muscle tone and clinical benefit. METHODS Global, randomized, controlled study to assess the efficacy and safety of abobotulinumtoxinA versus placebo in cerebral palsy… CONTINUE READING